Corbin Capital Partners »

Cytokinetics shares owned by Corbin Capital Partners

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Corbin Capital Partners from 13F filings

Historical chart of Corbin Capital Partners investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Corbin Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Corbin Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.3M 40k 83.49

More positions owned by Corbin Capital Partners

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New Call Option (CYTK)
Seritage Growth Pptys Cl A (SRG)
Indivior Ord (INDV)
Odyssey Marine Expl Com New (OMEX)
Alpha Tau Medical Ordinary Shares (DRTS)
Archer Aviation *w Exp 09/16/202 (ACHR.WS)
Terran Orbital Corporation (LLAP)
Hertz Global Hldgs Com New (HTZ)
Alpha Tau Medical *w Exp 03/07/202 (DRTSW)
Metals Acquisition *w Exp 06/15/202 (MTAL.WS)
Ree Automotive Shs Cl A New (REE)
Hippo Hldgs Com New (HIPO)
Slam Corp *w Exp 02/23/202 (SLAMW)

View all positions for Corbin Capital Partners

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics